Becton, Dickinson and Co. | BDX - Operating Expenses


Becton, Dickinson and Co. reported $24.13B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Avanos Medical USD 782.1M 625.97M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Cooper Companies USD 811.3M 113.5M Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Masimo USD 326.2M 2.4M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Solventum Corp USD 4.97B 3.08B Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026